MS4A18

Model summary

A human multi-pass membrane organizer that assembles and stabilizes receptor signaling platforms at the cell surface, particularly in hematopoietic lineages. By clustering cytokine and growth factor receptors with their proximal kinases, it modulates downstream pathways that regulate gene expression and cytokine responsiveness, generally dampening cell population proliferation while enhancing STAT phosphorylation when receptor complexes are engaged. Its four-helix membrane core anchors and positions partner proteins to control their localization and signaling output at the plasma membrane.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide contains IPR007237 (CD20-like, transmembrane domain, residues 155–245), a hallmark four-pass membrane module that creates a compact, multi-pass scaffold with short cytosolic N- and C-termini and two extracellular loops. This core is embedded within IPR030417 (Membrane-spanning 4-domains subfamily A, residues 89–324), which defines the broader family of MS4A-type membrane proteins. The ordered layout—an MS4A family envelope (89–324) containing a CD20-like four-helix bundle (155–245)—causes stable insertion into the plasma membrane and assembly into tetraspanin-like oligomers. Such assemblies typically lack catalytic motifs and instead function as membrane organizers that bind other proteins and receptors. This architecture therefore dictates a non-enzymatic role centered on multivalent contacts, supporting GO:0005515 protein binding as the molecular function.

2. 02

   From this scaffolded, multi-pass platform, signaling logic emerges.

   MS4A/CD20-like modules cluster and modulate receptor complexes, which directly feeds into GO:0007166 cell surface receptor signaling pathway. By corralling cytokine and growth factor receptors and their proximal kinases, the complex can tune downstream cascades that culminate in transcriptional outputs, aligning with GO:0010468 regulation of gene expression. The same spatial organization explains GO:0032880 regulation of protein localization: four-pass membrane scaffolds govern lateral mobility, endocytic routing, and membrane domain residency of their partner receptors and adaptors. In hematopoietic contexts, this spatial control restrains or promotes proliferation depending on the receptor cohort engaged; here, the predominant effect is to dampen proliferative drive, consistent with GO:0008285 negative regulation of cell population proliferation.

3. 03

   Cytokine responsiveness is further rationalized by the membrane-anchored clustering of cytokine receptors and JAK/STAT modules.

   By stabilizing receptor–kinase assemblies at the cell surface, the protein enhances STAT activation thresholds, matching GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein. This same assembly logic accounts for GO:0071345 cellular response to cytokine stimulus: cytokine exposure triggers receptor-proximal events that this membrane scaffold amplifies or gatekeeps.

4. 04

   The four-helix bundle and MS4A family identity unambiguously place the protein at the cell surface.

   The absence of luminal targeting signals and the presence of a CD20-like transmembrane core argue for a stable residence at the GO:0005886 plasma membrane, where receptor clustering and endocytic routing occur.

5. 05

   Mechanistically, I hypothesize that the protein forms homo-oligomeric and hetero-oligomeric platforms that recruit and modulate receptor and kinase assemblies in hematopoietic cells.

   Likely partners include cytokine and growth factor receptors (e.g., erythropoietin and interleukin receptors), Src-family and Syk/ZAP-70 kinases, and STAT transcription factors. By stabilizing these complexes at defined membrane microdomains, the protein tunes receptor signaling strength and duration, thereby controlling cytokine-driven transcription and restraining cell proliferation.